This website uses cookies to improve your experience. You can accept or reject analytics cookies
UK Influenza Pandemic Preparedness Strategy 2011
Pandemic Preparedness and ResponseHealth Guideline2011
United KingdomEnglishPDF
National
AI-Generated Document Summary
Objectives
Provide a United Kingdom-wide strategic framework for preparing for and responding to influenza pandemics, guiding public and private organisations while building on the 2007 framework, lessons from the 2009 H1N1 pandemic and current scientific evidence.The overarching aim is to minimise illness, deaths and disruption to society and the economy, while maintaining trust, essential services and the capacity of health and social care systems.
Detect a novel influenza virus and its arrival in the United Kingdom rapidly; assess severity, transmission, affected groups and wider public-health effects; and use surveillance to refine action as evidence develops.
Reduce transmission through respiratory, hand and home hygiene, staying at home when ill, symptom reporting, infection-control measures and proportionate behavioural interventions.
Minimise serious illness and deaths through timely access to antiviral medicines, antibiotics, clinical care and vaccination where available and appropriate.
Maintain health and social care capacity for high demand, workforce absence and intensive-care pressures, while preserving essential routine care where practicable.
Protect wider societal resilience by maintaining essential infrastructure, supplies, public services, business continuity, public safety, the rule of law and democratic processes.
Communicate clearly, accurately and transparently with the public, professionals, media and stakeholders to support informed decisions, personal responsibility and confidence in institutions.
Advance research on animal and human influenza, behavioural science, transmission and universal vaccines, and support international detection and scientific information-sharing.
Planning is intended to remain precautionary, proportionate, evidence-based and flexible rather than relying on a single reasonable worst-case scenario or treating international pandemic phases as fixed national triggers.The framework uses the non-linear phases Detection, Assessment, Treatment, Escalation and Recovery, which may be combined, revisited or entered in a different sequence according to local circumstances and service pressures.
Prepare for potentially widespread illness, including planning assumptions that up to 50 per cent of the population may develop symptoms over one or more 15-week waves and that up to 2.5 per cent of symptomatic people could die without effective treatment.
Plan for substantial workforce disruption, including up to 50 per cent of workers requiring time off over the pandemic and 15 to 20 per cent absent on a given day in a widespread and severe scenario.
Extend local capacity on a precautionary and reasonably practicable basis for 210,000 to 315,000 additional deaths over a possible 15-week period, with national support in more extreme circumstances.
Implementation
Deliver preparedness and response through a whole-of-society model that integrates established seasonal influenza, business-continuity and emergency-management arrangements with local, national and international coordination.A consistent UK-wide policy approach is combined with local flexibility, enabling decisions to reflect infection patterns, regional variation, organisational structures and demand on services across the four nations.
Lead health and social care preparedness through the Department of Health, which provides specialist advice to Ministers, government departments and responding organisations and maintains international liaison.
Coordinate UK public-health action through the Chief Medical Officers, health protection organisations and scientific advisers, working with England and the Devolved Administrations.
Use the National Security Council (Threats, Hazards, Resilience and Contingencies) Committee to oversee national preparations and Central Government activity, supported by the Cabinet Office Briefing Room and, where activated, the Scientific Advisory Group for Emergencies.
Develop local preparedness through Local Resilience Fora in England and Wales and Strategic Coordinating Groups in Scotland, alongside local organisations, emergency planners, health services, social care and other partners.
Coordinate international surveillance, preparedness and information exchange with the World Health Organization, European Union bodies and other international partners.
Operational delivery begins with intelligence gathering, enhanced surveillance, diagnostics, testing, contact tracing, early case assessment and public communications.Assessment measures may include active case finding, self-isolation, treatment and risk-based antiviral prophylaxis for close or vulnerable contacts; sustained community transmission informs transition towards population-level treatment arrangements.
Build surveillance on established seasonal influenza systems, using primary-care consultations, laboratory and sentinel data, telephone and web advisory services, hospital data, excess mortality, vaccination data, community surveys and sero-prevalence studies.
Monitor severe disease, risk groups, geographical and age-specific spread, hospitalisation, mortality, antiviral resistance, countermeasure uptake, vaccine safety and effectiveness.
Deploy Government antiviral stockpiles, Antiviral Collection Points and the National Pandemic Flu Service, an online and telephone self-assessment service, when individual clinical assessment becomes impractical because of demand.
Maintain antibiotic stockpiles for secondary bacterial complications and prepare vaccine procurement, licensing, prioritisation and phased delivery arrangements, guided by emerging risk and expert advice from the Joint Committee on Vaccination and Immunisation.
Manage escalation through surge capacity, triage, prioritisation, progressive reduction of non-essential activity, support for home-based care and continuity of essential community services.
Coordinate recovery by restoring services, addressing postponed care, staff fatigue, depleted supplies and maintenance backlogs, preparing for resurgence and conducting post-incident reviews to share lessons.
Public communication should be coordinated nationally and locally, informed by behavioural science, tailored to different audiences and delivered through press briefings, websites, social media, telephone help lines and interactive channels.Communication should explain uncertainty, symptoms, protective actions, service access, self-care, treatment and vaccination, while tracking public attitudes and ensuring vulnerable groups can access advice.
All sectors should exercise and review scalable business-continuity arrangements, identify interdependencies and supplier risks, and sustain critical infrastructure, utilities, food, transport, finance, emergency provision, benefits and other essential services.Measures such as border closures, routine mass-gathering restrictions and broad public-transport controls are not planned; instead, interventions should be targeted, locally risk-assessed and restricted to what is necessary for public health.
Monitoring & Evaluation
Pandemic monitoring is centred on rapid detection, characterisation and continuous surveillance of a novel influenza virus, with response measures adapted as evidence emerges on transmission, severity, risk groups, service demand and geographical variation.The framework uses five non-linear phases, Detection, Assessment, Treatment, Escalation and Recovery, which may be combined, revisited or entered in a different sequence according to conditions.
Detect and assess early cases through enhanced United Kingdom surveillance, virus-specific diagnostics, active case finding, testing, contact tracing and analysis of cases, contacts and early deaths.
Monitor clinical, epidemiological and virological features, including severe cases, affected risk groups, age-specific and geographical spread, hospitalisation, critical-care demand, mortality, antiviral resistance, vaccine uptake, vaccine safety and vaccine effectiveness.
Use established seasonal influenza systems, strengthened where necessary through more frequent data collection, primary-care consultations, telephone and web advisory services, sentinel virological schemes, laboratory data, hospital data, excess mortality information, community surveys and sero-prevalence studies.
Share early data internationally with the World Health Organization, European Centre for Disease Prevention and Control and other countries, while using the World Health Organization Global Influenza Surveillance Network to monitor circulating viruses and detect those with pandemic potential.
Apply phase-transition indicators, including identification of the novel virus in United Kingdom patients, sustained community transmission, detailed surveillance of community and hospital cases and deaths, service demand exceeding capacity, and subsequently reduced influenza activity alongside acceptable service capacity.
Assess response pressure through illness severity and distribution, intensive-care requirements, healthcare capacity, sickness absence, supply continuity, service disruption, and pressure on mortuary and undertaker services.
Maintain statistical reporting standards and publish surveillance and public-health-threat data transparently, using comparable approaches across the four countries where possible and following the Code of Practice for Official Statistics.
Track public awareness, attitudes and engagement through market research and surveys, including whether messages reach vulnerable groups equitably.
Review planning assumptions as scientific and operational evidence develops, including annual review of the reasonable worst-case scenario.
Exercise response and business-continuity arrangements with partner organisations to test roles, responsibilities, assumptions, coordination and staff familiarity.
Conduct post-incident review to identify what worked, what requires improvement and lessons learned, then share findings to strengthen future preparedness and recovery.
Accountability is supported by ministerial decisions informed by scientific and clinical advice, coordination among Chief Medical Officers and public-health organisations, and the Department of Health’s leadership of national health and social-care preparedness.Operational responsibility for capacity management rests with local health organisations, while Ministers of the four countries decide vaccination priority groups.The material does not specify a single quantified performance-indicator framework, universal reporting timetable, or independent accountability mechanism.
Costing & Financing
No dedicated pandemic-preparedness budget, activity-level costing, funding source, resource-mobilisation target or quantified funding gap is specified.The framework nonetheless identifies substantial resource requirements, including antiviral and antibiotic stockpiles, limited pre-pandemic vaccine supplies, potential advance vaccine supply agreements, surveillance infrastructure, critical-care surge capacity, business-continuity arrangements and recovery from depleted supplies and postponed care.
Recognise that economic estimates are illustrative because information is limited and pandemic impacts depend on disease characteristics, service capacity and behavioural responses.
Use an illustrative 2012 United Kingdom gross domestic product baseline of approximately 1.6 trillion Pounds sterling, under which illness-related absence affecting 50% of employees and averaging 3.5% of a working year could imply an economic loss of approximately 28 billion Pounds sterling.
Recognise that an alternative assumption of absence affecting 25% of workers would halve the illustrative loss, while effective business-continuity planning could mitigate economic effects.
Consider the historical variability of gross domestic product impacts across pandemics, with estimates ranging from losses to gains for the 1918-1919 and 1957-1958 pandemics and smaller estimated losses for 1968-1969 and 2009-2010.
Account for potentially substantial economic and social consequences of border closures, restrictions on gatherings and school closures, including possible disruption to food, pharmaceutical and other essential supplies and disproportionate effects on health and social-care workforces.
Consider planning and preparation costs in relation to the risk posed by unpredictable, high-impact events.
Capacity constraints rather than monetary allocations are emphasised, including workforce absence, limited critical-care capacity, medicines and essential-material shortages, infrastructure and supply-chain pressures, and maintenance or replacement needs during recovery.